Nintedanib 656247-17-5

Nintedanib is an anti-angiogenesis anti-cancer agent.

Nintedanib is an indolinone-derived drug that inhibits the process

of blood vessel formation (angiogenesis)Nintedanib,

marketed under the brand names Ofev and Vargatef,

is an oral medication used for the treatment of idiopathic pulmonary fibrosis (IPF)

and along with other medications for some types of non-small-cell lung cancer.

Common side effects include abdominal pain, vomiting, and diarrhea.

It is a small molecule tyrosine-kinase inhibitor, targeting vascular endothelial

growth factor receptor (VEGFR), fibroblast growth factor receptor (FGFR)

and platelet derived growth factor receptor (R)